K. Kobayashi

A. Gemma, Kunihiko Kobayashi, S. Oizumi, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Effectiveness of EGFR‐TKI rechallenge immediately after PD‐1 blockade failure

Kunihiko Kobayashi, K. Kaira, H. Kagamu, 2021, Thoracic cancer.

Interstitial lung disease associated with gefitinib in Japanese patients with EGFR-mutated non-small-cell lung cancer: combined analysis of two Phase III trials (NEJ 002 and WJTOG 3405).

T. Mitsudomi, Y. Nakanishi, Kunihiko Kobayashi, 2013, Japanese journal of clinical oncology.

Phase III study comparing gefitinib monotherapy (G) to combination therapy with gefitinib, carboplatin, and pemetrexed (GCP) for untreated patients (pts) with advanced non-small cell lung cancer (NSCLC) with EGFR mutations (NEJ009).

A. Gemma, Y. Hosomi, S. Morita, 2018 .

Importance of the cytological samples for the epidermal growth factor receptor gene mutation test for non‐small cell lung cancer

Kunihiko Kobayashi, K. Hagiwara, K. Kobayashi, 2013, Cancer science.

Comparison of Methods for Profiling O-Glycosylation

Nicolle H. Packer, Naoyuki Taniguchi, Daniel Kolarich, 2009, Molecular & Cellular Proteomics.

Intestinal alkalization as a possible preventive mechanism in irinotecan (CPT-11)-induced diarrhea.

Y. Matsuzaki, Kunihiko Kobayashi, P. Latham, 2002, Cancer research.

Combination therapy with carboplatin and paclitaxel for small cell lung cancer.

Kunihiko Kobayashi, H. Kagamu, O. Yamaguchi, 2019, Respiratory investigation.

Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002).

A. Gemma, S. Morita, Kunihiko Kobayashi, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab

Kunihiko Kobayashi, K. Kaira, H. Kagamu, 2019, Thoracic cancer.

Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1

Kunihiko Kobayashi, K. Kaira, H. Kagamu, 2022, BMC cancer.

Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese hamster ovary cells.

Eiji Katsura, Kunihiko Kobayashi, S. Takeuchi, 2004, Environmental health perspectives.

Possible involvement in oncogenesis of a single base mutation in an internal ribosome entry site of Epstein–Barr nuclear antigen 1 mRNA

T. Ebihara, H. Kikuta, N. Ishiguro, 2004, Journal of medical virology.

CD4+ T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy

K. Horimoto, K. Fukui, M. Kitazawa, 2019, Cancer Immunology Research.

Phase III study comparing bevacizumab plus erlotinib to erlotinib in patients with untreated NSCLC harboring activating EGFR mutations: NEJ026.

A. Gemma, M. Okada, S. Morita, 2018 .

Repetitive stretch suppresses denervation‐induced atrophy of soleus muscle in rats

M. Sokabe, K. Hayakawa, N. Sasai, 2009, Muscle & nerve.

Pre‐existing interstitial lung disease does not affect prognosis in non‐small cell lung cancer patients with PD‐L1 expression ≥50% on first‐line pembrolizumab

Kunihiko Kobayashi, K. Kaira, H. Kagamu, 2020, Thoracic cancer.

Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp.

Huqun, Tomoaki Tanaka, Kunihiko Kobayashi, 2005, Cancer research.

Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with EGFR Mutations

Koichi Yamazaki, Satoshi Morita, Masahiro Fukuoka, 2009, Clinical Cancer Research.

Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancer.

A. Yoshimura, A. Gemma, T. Okano, 2004, Lung cancer.

Effects of a diphenyl ether-type herbicide, chlornitrofen, and its amino derivative on androgen and estrogen receptor activities.

Yoshihiro Hori, Eiji Katsura, Kunihiko Kobayashi, 2003, Environmental health perspectives.

NEJ026: Final overall survival analysis of bevacizumab plus erlotinib treatment for NSCLC patients harboring activating EGFR-mutations.

A. Gemma, M. Okada, S. Morita, 2020 .

First-Line Gefitinib in Patients Aged 75 or Older With Advanced Non–Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations: NEJ 003 Study

S. Kudoh, Tomoaki Tanaka, Kunihiko Kobayashi, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Quality of life with gefitinib in patients with EGFR-mutated non-small cell lung cancer: quality of life analysis of North East Japan Study Group 002 Trial.

A. Gemma, S. Morita, Kunihiko Kobayashi, 2012, The oncologist.

First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy.

A. Gemma, Tomoaki Tanaka, S. Morita, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated EGFR

Y. Hosomi, M. Seike, S. Morita, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation

Kunihiko Kobayashi, K. Kaira, H. Kagamu, 2019, Cancer Chemotherapy and Pharmacology.

Osimertinib versus osimertinib plus chemotherapy for non-small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial.

K. Sugio, Kunihiko Kobayashi, S. Oizumi, 2021, European journal of cancer.

Snake coiled fibres in rat soleus muscle in chloroquine induced myopathy share immunohistochemical characteristics with amyloid depositions in Alzheimer's disease brain tissue

Kunihiko Kobayashi, N. Fujii, R. Fukatsu, 1997, International journal of experimental pathology.

Metabolic Changes in Human CD36 Deficiency Displayed by Glucose Loading

H. Chiba, H. Yanai, S. Hui, 2001, Thrombosis and Haemostasis.

Differential gene expression of S100 protein family in leukocytes from patients with Kawasaki disease

Kunihiko Kobayashi, T. Ebihara, Xiaomin Ma, 2005, European Journal of Pediatrics.

Involvement of PI3K/Akt/TOR pathway in stretch‐induced hypertrophy of myotubes

M. Sokabe, K. Hayakawa, N. Sasai, 2010, Muscle & nerve.

Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: a possible role for apolipoprotein E in Alzheimer's disease

Kunihiko Kobayashi, H. Chiba, N. Fujii, 1997, Brain Research.

In vitro investigation of a combination of two drugs, cisplatin and carboplatin, as a function of the area under thec/t curve

S. Kudoh, Kunihiko Kobayashi, H. Niitani, 2005, Journal of Cancer Research and Clinical Oncology.

Lipoprotein profiles in children with two common cholesteryl ester transfer protein gene mutations, D442G and I14A, during the first year of life.

H. Tsukahara, Kunihiko Kobayashi, T. Miida, 2009, Clinica chimica acta; international journal of clinical chemistry.

Reduced apolipoprotein E-rich high-density lipoprotein level at birth is restored to the normal range in patients with familial hypercholesterolemia in the first year of life.

H. Tsukahara, Kunihiko Kobayashi, T. Miida, 2008, The Journal of clinical endocrinology and metabolism.

Validity and Reliability of the Japanese Version of the 10-Item Perceived Efficacy in Patient-Physician Interactions (PEPPI-10) Scale in Breast Cancer Outpatients.

T. Ohkubo, Kenichi Inoue, K. Kubota, 2019, The Tohoku journal of experimental medicine.

Apolipoproteins in rat cerebrospinal fluid: A comparison with plasma lipoprotein metabolism and effect of aging

Kunihiko Kobayashi, K. Tashiro, A. Ogata, 1991, Neuroscience Letters.

Relationship Between Oxidative Stress and Antioxidant Systems in the Liver of Patients With Wilson Disease: Hepatic Manifestation in Wilson Disease as a Consequence of Augmented Oxidative Stress

H. Tsukahara, S. Uemoto, Kunihiko Kobayashi, 2006, Pediatric Research.

Pharmacokinetics of a New Fentanyl Tape with a Novel Delivery System of Transdermal Matrix Patches in Patients with Cancer Pain

S. Saito, K. Fujiwara, K. Shimada, 2013, Oncology.

Risk factors for tumor lysis syndrome in childhood acute myeloid leukemia treated with a uniform protocol without rasburicase prophylaxis

Kunihiko Kobayashi, D. Suzuki, R. Kobayashi, 2015, Leukemia & lymphoma.

Different incidence of interstitial lung disease according to different kinds of EGFR‐tyrosine kinase inhibitors administered immediately before and/or after anti‐PD‐1 antibodies in lung cancer

K. Kaira, H. Kagamu, O. Yamaguchi, 2019, Thoracic cancer.

Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients

Kunihiko Kobayashi, K. Kaira, H. Kagamu, 2019, Thoracic cancer.

Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer

Kunihiko Kobayashi, K. Kaira, H. Kagamu, 2019, Cancer Chemotherapy and Pharmacology.

Wiskott-Aldrich syndrome with unusual clinical features similar to juvenile myelomonocytic leukemia

M. Yamada, Kunihiko Kobayashi, D. Suzuki, 2012, International Journal of Hematology.

Syndrome Inherited Mutation in the Wiskott-Aldrich Spontaneous In Vivo Reversion of an Sakiyama

M. Yamada, T. Ariga, Kunihiko Kobayashi, 2001 .

Necrotizing funisitis: clinical significance and association with chronic lung disease in premature infants.

Y. Fukazawa, T. Matsuda, S. Fujimoto, 1997, American journal of obstetrics and gynecology.

A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer

Kunihiko Kobayashi, M. Tsuchida, H. Miyazawa, 2017, PloS one.

Reliability of the peptide nucleic acid‐locked nucleic acid polymerase chain reaction clamp‐based test for epidermal growth factor receptor mutations integrated into the clinical practice for non‐small cell lung cancers

Tomoaki Tanaka, Kunihiko Kobayashi, M. Kanazawa, 2007, Cancer science.

CT Features of Epidermal Growth Factor Receptor–Mutated Adenocarcinoma of the Lung: Comparison with Nonmutated Adenocarcinoma

F. Sakai, M. Hasegawa, H. Ishida, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial.

M. Seike, M. Okada, S. Morita, 2021, The Lancet. Respiratory medicine.

Treatments and outcomes of advanced/recurrent non-small cell lung cancer harboring the EGFR T790M mutation: a retrospective observational study of 141 patients in Japan.

Y. Ishii, Kunihiko Kobayashi, Makoto Nishino, 2016, Japanese journal of clinical oncology.

Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study.

M. Seike, K. Sugio, Kunihiko Kobayashi, 2023, European journal of cancer.

Phase I Study Evaluating the Combination of Afatinib with Carboplatin and Pemetrexed After First-line EGFR-TKIs

Kunihiko Kobayashi, T. Nukiwa, T. Kikuchi, 2018, AntiCancer Research.

Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations

A. Gemma, S. Morita, Kunihiko Kobayashi, 2018, ESMO Open.

Carcinomatous meningitis and EGFR mutation

T. Okano, Kunihiko Kobayashi, A. Kawashima, 2015 .

Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002).

A. Gemma, Kunihiko Kobayashi, S. Oizumi, 2015, Japanese journal of clinical oncology.

Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy

A. Gemma, M. Seike, K. Kubota, 2016, SpringerPlus.

A. Gemma, M. Seike, K. Kubota, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Severe hepatotoxicity due to osimertinib after nivolumab therapy in patients with non‐small cell lung cancer harboring EGFR mutation

Kunihiko Kobayashi, T. Kawasaki, K. Kaira, 2020, Thoracic cancer.

First-line gefitinib for elderly patients with advanced NSCLC harboring EGFR mutations. A combined analysis of North-East Japan Study Group studies

A. Gemma, Kunihiko Kobayashi, S. Oizumi, 2015, Expert opinion on pharmacotherapy.

Final overall survival results of NEJ002, a phase III trial comparing gefitinib to carboplatin (CBDCA) plus paclitaxel (TXL) as the first-line treatment for advanced non-small cell lung cancer (NSCLC) with EGFR mutations.

A. Gemma, Kunihiko Kobayashi, S. Oizumi, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effectiveness of Gefitinib against Non–Small-Cell Lung Cancer with the Uncommon EGFR Mutations G719X and L861Q

Koichi Hagiwara, Yuji Minegishi, Akira Inoue, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Importance of the cytological samples for the epidermal growth factor receptor gene mutation test for non‐small cell lung cancer

K. Hagiwara, K. Kobayashi, 2013, Cancer science.

Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC)

Kunihiko Kobayashi, K. Hagiwara, K. Kobayashi, 2013, Targeted Oncology.

3) Non-small Cell Lung Cancer

Kunihiko Kobayashi, Kunihiko Kobayashi, K. Kobayashi, 2012 .

c-kit Activating Mutations and Mast Cell Proliferation in Human Leukemia

M. Peitsch, A. Fischer, W. Friedrich, 2017 .

Clinical Benefit of Chemotherapy for Small-Cell Lung Cancer Patients with Extremely Poor Performance Status (PS)

Kunihiko Kobayashi, H. Kagamu, O. Yamaguchi, 2018 .

A phase II trial of afatinib (BIBW 2992) in patients (pts) with advanced non-small cell lung cancer previously treated with erlotinib (E) or gefitinib (G).

Y. Ichinose, H. Saka, K. Kiura, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Central nervous system manifestations after steroid pulse therapy in systemic lupus erythematosus

I. Kobayashi, Kunihiko Kobayashi, M. Okano, 2002, European Journal of Pediatrics.

[Chemotherapy-induced diarrhea].

Kunihiko Kobayashi, K. Kobayashi, 2003, Gan to kagaku ryoho. Cancer & chemotherapy.

pH‐dependent uptake of irinotecan and its active metabolite, SN‐38, by intestinal cells

S. Kudoh, Y. Matsuzaki, Kunihiko Kobayashi, 1999, International journal of cancer.

Bevacizumab plus chemotherapy in nonsquamous non‐small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B

A. Gemma, M. Seike, K. Kubota, 2020, Thoracic cancer.

A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A.

Kunihiko Kobayashi, M. Maemondo, M. Nishitsuji, 2016, Lung cancer.

Fluctuation of lipoprotein metabolism linked with bile acid-activated liver nuclear receptors in Alagille syndrome.

H. Tsukahara, T. Miida, K. Murayama, 2008, Atherosclerosis.

Prophylactic administration of voriconazole with two different doses for invasive fungal infection in children and adolescents with acute myeloid leukemia.

Kunihiko Kobayashi, D. Suzuki, R. Kobayashi, 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Acute promyelocytic leukemia after living donor partial orthotopic liver transplantation in two Japanese girls

Kunihiko Kobayashi, H. Furukawa, R. Kobayashi, 2005, Leukemia & lymphoma.

Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects.

H. Tsukahara, Kunihiko Kobayashi, T. Miida, 2009, Metabolism: clinical and experimental.

4 and other hand , the Bcl-2 proto-oncogene product ( Bakhshi

Y. Tsujimoto, S. Shimizu, Kunihiko Kobayashi, 2013 .

First-line gefitinib versus first-line chemotherapy by carboplatin (CBDCA) plus paclitaxel (TXL) in non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations: A phase III study (002) by North East Japan Gefitinib Study Group.

A. Gemma, Kunihiko Kobayashi, S. Oizumi, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recovery of the Sensitivity to Anti-PD-1 Antibody by Celecoxib in Lung Cancer

Kunihiko Kobayashi, K. Kaira, H. Kagamu, 2020, AntiCancer Research.

First-line gefitinib for elderly patients with advanced non-small cell lung cancer (NSCLC) harboring EGFR mutations: A combined analysis of NEJ studies.

A. Gemma, T. Harada, M. Maemondo, 2012 .

A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol

Kunihiko Kobayashi, Satoshi Watanabe, T. Asao, 2022, BMC Cancer.

Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis.

Huqun, S. Abe, Y. Inoue, 2007, American journal of respiratory and critical care medicine.

Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: application of a general linear model.

M. Shibuya, K. Eguchi, Y. Ohashi, 2003, Japanese journal of clinical oncology.

Depletion of High-density Lipoprotein and Appearance of Triglyceride-rich Low-density Lipoprotein in a Japanese Patient With FIC1 Deficiency Manifesting Benign Recurrent Intrahepatic Cholestasis

H. Tsukahara, M. Hasegawa, Kunihiko Kobayashi, 2007, Journal of pediatric gastroenterology and nutrition.

Unique character and metabolism of high density lipoprotein (HDL) in fetus.

Kunihiko Kobayashi, H. Chiba, H. Yanai, 2002, Atherosclerosis.

Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study)

Kunihiko Kobayashi, H. Ohtsu, M. Yamasaki, 2021, Therapeutic advances in medical oncology.

Clinical significance of circulating tumor cells and free DNA in non-small cell lung cancer.

Kunihiko Kobayashi, K. Isobe, K. Sugino, 2012, Anticancer research.

Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 Study

Kazuhisa Takahashi, Kunihiko Kobayashi, M. Yamasaki, 2022, Cancers.

Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy.

S. Morita, Kazuhisa Takahashi, S. Yamanda, 2020, Lung cancer.

Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study.

K. Uematsu, S. Morita, Kazuhisa Takahashi, 2019, The oncologist.

Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.

S. Morita, Kazuhisa Takahashi, Kunihiko Kobayashi, 2018, The oncologist.

Pretreatment Glasgow prognostic score predicts survival among patients with high PD‐L1 expression administered first‐line pembrolizumab monotherapy for non‐small cell lung cancer

Kunihiko Kobayashi, K. Kaira, H. Kagamu, 2021, Cancer medicine.

Efficacy and Safety of Anti-Programed Death-1 Blockade in Previously Treated Large-Cell Neuroendocrine Carcinoma

Kunihiko Kobayashi, K. Kaira, H. Kagamu, 2021, Chemotherapy.

Risk factors for delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia and lymphoma

Kunihiko Kobayashi, D. Suzuki, M. Yanagi, 2021, International Journal of Hematology.

Immunohistochemical analysis of Mallory bodies in Wilsonian and non‐Wilsonian hepatic copper toxicosis

K. Zatloukal, H. Denk, C. Langner, 2004, Hepatology.

Effects of arginine treatment on nutrition, growth and urea cycle function in seven Japanese boys with late-onset ornithine transcarbamylase deficiency

Kunihiko Kobayashi, Shigenori Yamamoto, K. Murayama, 2006, European Journal of Pediatrics.

Bacteremia during neutropenia is a predictive factor for invasive fungal infection in children

Kunihiko Kobayashi, D. Suzuki, R. Kobayashi, 2013, Pediatrics international : official journal of the Japan Pediatric Society.

Successful treatment of steroid-dependent gastrointestinal acute graft-versus-host disease with mesenchymal stromal cells administered more than 100 days after allo-HCT

Kunihiko Kobayashi, D. Suzuki, M. Yanagi, 2022, Blood cell therapy.

Using a quality of life (QoL)-monitor: preliminary results of a randomized trial in Dutch patients with early breast cancer

H. Putter, J. Nortier, Kenichi Inoue, 2020, Quality of Life Research.

Irinotecan (CPT-11) in combination with weekly administration of cisplatin (CDDP) for non-small-cell lung cancer

S. Hibino, M. Shibuya, Kunihiko Kobayashi, 1998, Cancer Chemotherapy and Pharmacology.

Nitric oxide synthesis in ornithine transcarbamylase deficiency: possible involvement of low no synthesis in clinical manifestations of urea cycle defect.

Kunihiko Kobayashi, K. Murayama, T. Yorifuji, 2004, The Journal of pediatrics.

Paranasal sinusitis at the initiation of chemotherapy is a risk factor for invasive fungal disease in children and adolescents with cancer

Kunihiko Kobayashi, D. Suzuki, M. Yanagi, 2021, Supportive Care in Cancer.

Comparison of myelosuppression using the D‐index between children and adolescents/young adults with acute lymphoblastic leukemia during induction chemotherapy

D. Suzuki, M. Yanagi, R. Kobayashi, 2020, Pediatric blood & cancer.

Risk Factors for Invasive Fungal Infection in Children and Adolescents With Hematologic and Malignant Diseases: A 10-year Analysis in a Single Institute in Japan

Kunihiko Kobayashi, D. Suzuki, R. Kobayashi, 2018, The Pediatric infectious disease journal.

Differential efficacy of empirical antibiotic therapy for febrile neutropenia in adolescent/young adult (AYA) and child patients

Kunihiko Kobayashi, D. Suzuki, Makoto Yoshida, 2018, International Journal of Hematology.

Impact of the D-index deduced from duration and intensity of neutropenia following chemotherapy on the risk of invasive fungal infection in pediatric acute myeloid leukemia

Kunihiko Kobayashi, D. Suzuki, R. Kobayashi, 2018, International Journal of Hematology.

Meropenem versus piperacillin/tazobactam with or without immunoglobulin as second-line therapy for febrile neutropenia in pediatric patients.

Kunihiko Kobayashi, D. Suzuki, R. Kobayashi, 2017, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers

Kunihiko Kobayashi, K. Kaira, H. Kagamu, 2021, Frontiers in Oncology.

Illness Perceptions and Quality of Life in Patients with Non-Small-Cell Lung Cancer: A 3-Month Follow-Up Pilot Study

H. Putter, J. Nortier, Kenichi Inoue, 2020, Patient related outcome measures.

Study of upper respiratory tract bacterial flora: first report. Variations in upper respiratory tract bacterial flora in patients with acute upper respiratory tract infection and healthy subjects and variations by subject age

K. Kaga, Y. Okamoto, Kunihiko Kobayashi, 2006, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Blood Mononuclear Cells Syndrome Protein Expression in Peripheral Cytometric Analysis of Wiskott-Aldrich Wiskott-Aldrich Syndrome by Flow Determination of Carrier Status for the Kobayashi and Yukio

M. Yamada, I. Kobayashi, T. Ariga, 2000 .

Human Metapneumovirus Infection in Japanese Children

Kunihiko Kobayashi, H. Ishiko, T. Ebihara, 2004, Journal of Clinical Microbiology.

Comparison of the seroprevalence of human metapneumovirus and human respiratory syncytial virus

Kunihiko Kobayashi, H. Ishiko, T. Ebihara, 2004, Journal of medical virology.

Seroprevalence of human metapneumovirus in Japan

Kunihiko Kobayashi, T. Ebihara, Xiaomin Ma, 2003, Journal of medical virology.

Comparison of a Lateral-Flow Immunochromatography Assay with Real-Time Reverse Transcription-PCR for Detection of Human Metapneumovirus

H. Ishiko, Akio Hayashi, H. Kikuta, 2008, Journal of Clinical Microbiology.

Impact of folate therapy on combined immunodeficiency secondary to hereditary folate malabsorption.

M. Yamada, Natsuko Chida, Kunihiko Kobayashi, 2014, Clinical immunology.

Biochemical Studies on Sulfate-reducing Bacteria

Kunihiko Kobayashi, E. Takahashi, M. Ishimoto, 1957 .

Tumor lysis syndrome as a risk factor for posterior reversible encephalopathy syndrome in children with hematological malignancies

Kunihiko Kobayashi, D. Suzuki, R. Kobayashi, 2014, International Journal of Hematology.

Effects of midstream collection and the menstrual cycle on urine particles and dipstick urinalysis among healthy females.

Kunihiko Kobayashi, H. Chiba, H. Yanai, 2003, Clinical chemistry.

Transgene of MIF induces podocyte injury and progressive mesangial sclerosis in the mouse kidney.

Kunihiko Kobayashi, Y. Sado, Y. Ninomiya, 2004, Kidney international.

A phase II study of erlotinib monotherapy in pre-treated non-small cell lung cancer without EGFR gene mutation who have never/light smoking history: re-evaluation of EGFR gene status (NEJ006/TCOG0903).

A. Gemma, Y. Ishii, Kunihiko Kobayashi, 2014, Lung cancer.

Phase II Study of Amrubicin Combined with Carboplatin for Thymic Carcinoma and Invasive Thymoma: North Japan Lung Cancer Group Study 0803

Kunihiko Kobayashi, M. Maemondo, T. Nukiwa, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase II study of amrubicin (AMR) and carboplatin (CBDCA) for invasive thymoma (IT) and thymic carcinoma (TC): NJLCG0803.

Kunihiko Kobayashi, M. Maemondo, T. Nukiwa, 2013 .

Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion.

Kunihiko Kobayashi, H. Nitanda, H. Ishida, 2017, Lung cancer.

Wernicke encephalopathy in a lung cancer patient during treatment with nivolumab

Kunihiko Kobayashi, T. Akechi, H. Kagamu, 2018, Palliative and Supportive Care.

Effectiveness of a Self-Monitoring Quality of Life Intervention For Patients with Cancer Receiving Palliative Care: A Randomized Controlled Clinical Trial

T. Ohkubo, E. Matsushima, Kunihiko Kobayashi, 2019, Asian Pacific journal of cancer prevention : APJCP.

Effects of a Self-Monitoring Quality of Life Intervention for Patients with Cancer Receiving Palliative Care in Japan: Study Protocol for a Randomized Controlled Trial

T. Ohkubo, E. Matsushima, Kunihiko Kobayashi, 2018, Asian Pacific journal of cancer prevention : APJCP.

Phase II study of bi-weekly docetaxel and carboplatin with concurrent thoracic radiation therapy followed by consolidation chemotherapy with docetaxel plus carboplatin for stage III unresectable non-small cell lung cancer.

Kunihiko Kobayashi, S. Yoneda, H. Sakai, 2004, Lung cancer.